Skip to main content

NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.

Publication ,  Journal Article
Colevas, AD; Cmelak, AJ; Pfister, DG; Spencer, S; Adkins, D; Birkeland, AC; Brizel, DM; Busse, PM; Caudell, JJ; Durm, G; Fakhry, C; Geiger, JL ...
Published in: J Natl Compr Canc Netw
February 2025

The NCCN Guidelines for Head and Neck Cancers address tumors arising in the oral cavity (including mucosal lip), pharynx, larynx, and paranasal sinuses, as well as occult primary cancer, salivary gland cancer, and mucosal melanoma (MM). The specific site of disease, stage, and pathologic findings guide treatment (eg, the appropriate surgical procedure, radiation targets, dose and fractionation of radiation, indications for systemic therapy). The NCCN Head and Neck Cancers Panel meets at least annually to review comments from reviewers within their institutions, examine relevant new data from publications and abstracts, and reevaluate and update their recommendations. These NCCN Guidelines Insights summarize the panel's most recent recommendations regarding management of nasopharynx cancer and ongoing research in this area.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2025

Volume

23

Issue

2

Start / End Page

2 / 11

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • Education, Medical, Continuing
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Colevas, A. D., Cmelak, A. J., Pfister, D. G., Spencer, S., Adkins, D., Birkeland, A. C., … Darlow, S. D. (2025). NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw, 23(2), 2–11. https://doi.org/10.6004/jnccn.2025.0007
Colevas, A Dimitrios, Anthony J. Cmelak, David G. Pfister, Sharon Spencer, Douglas Adkins, Andrew C. Birkeland, David M. Brizel, et al. “NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.J Natl Compr Canc Netw 23, no. 2 (February 2025): 2–11. https://doi.org/10.6004/jnccn.2025.0007.
Colevas AD, Cmelak AJ, Pfister DG, Spencer S, Adkins D, Birkeland AC, et al. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw. 2025 Feb;23(2):2–11.
Colevas, A. Dimitrios, et al. “NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025.J Natl Compr Canc Netw, vol. 23, no. 2, Feb. 2025, pp. 2–11. Pubmed, doi:10.6004/jnccn.2025.0007.
Colevas AD, Cmelak AJ, Pfister DG, Spencer S, Adkins D, Birkeland AC, Brizel DM, Busse PM, Caudell JJ, Durm G, Fakhry C, Galloway T, Geiger JL, Gillison ML, Glastonbury C, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Juloori A, Kase M, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Price K, Rocco JW, Rodriguez CP, Schwartz D, Shah JP, Sher D, John MS, Wang H, Weinstein G, Worden F, Bruce JY, Yom SS, Zhen W, Montgomery S, Darlow SD. NCCN Guidelines® Insights: Head and Neck Cancers, Version 2.2025. J Natl Compr Canc Netw. 2025 Feb;23(2):2–11.

Published In

J Natl Compr Canc Netw

DOI

EISSN

1540-1413

Publication Date

February 2025

Volume

23

Issue

2

Start / End Page

2 / 11

Location

United States

Related Subject Headings

  • Practice Guidelines as Topic
  • Oncology & Carcinogenesis
  • Humans
  • Head and Neck Neoplasms
  • Education, Medical, Continuing
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis